Cognyte Software (NASDAQ:CGNT) Share Price Crosses Above 200 Day Moving Average of $6.19

Cognyte Software Ltd. (NASDAQ:CGNT)’s share price passed above its 200-day moving average during trading on Friday . The stock has a 200-day moving average of $6.19 and traded as high as $6.59. Cognyte Software shares last traded at $6.42, with a volume of 425,303 shares trading hands.

Analysts Set New Price Targets

CGNT has been the subject of a number of research analyst reports. StockNews.com upgraded Cognyte Software from a “buy” rating to a “strong-buy” rating in a research note on Wednesday, April 10th. Wedbush increased their price target on Cognyte Software from $5.00 to $8.00 and gave the company a “neutral” rating in a research note on Thursday, April 11th. Evercore ISI increased their price target on Cognyte Software from $5.00 to $7.50 and gave the company an “in-line” rating in a research note on Wednesday, April 10th. Finally, Needham & Company LLC reiterated a “hold” rating on shares of Cognyte Software in a research note on Tuesday, April 9th.

Cognyte Software Stock Down 1.8 %

The stock has a market capitalization of $455.97 million, a PE ratio of -27.91 and a beta of 1.68. The firm has a 50 day moving average price of $7.52 and a 200-day moving average price of $6.19.

Institutional Inflows and Outflows

Institutional investors have recently modified their holdings of the company. Tower Research Capital LLC TRC acquired a new stake in Cognyte Software during the fourth quarter worth about $37,000. Quantbot Technologies LP acquired a new stake in Cognyte Software during the first quarter worth about $45,000. M&T Bank Corp grew its holdings in Cognyte Software by 52.8% during the first quarter. M&T Bank Corp now owns 16,559 shares of the medical device company’s stock worth $56,000 after acquiring an additional 5,724 shares during the period. Lazard Asset Management LLC acquired a new stake in Cognyte Software during the second quarter worth about $56,000. Finally, State of Wyoming grew its holdings in Cognyte Software by 72.9% in the second quarter. State of Wyoming now owns 9,794 shares of the medical device company’s stock valued at $60,000 after purchasing an additional 4,130 shares during the period. 72.92% of the stock is currently owned by hedge funds and other institutional investors.

Cognyte Software Company Profile

Cognyte Software Ltd. provides an investigative analytics software to governments and enterprises worldwide. Its Actionable Intelligence for a Safer World, an open software designed to help governments and enterprises accelerate and enhance the effectiveness of investigations. The company also offers network intelligence analytics, open source and threat intelligence analytics, and operational intelligence analytics solutions.